Skip to main content
Fig. 3 | BMC Endocrine Disorders

Fig. 3

From: Diabetes treatment intensification and associated changes in HbA1c and body mass index: a cohort study

Fig. 3

Median HbA1c and BMI and confidence intervals by intensification group over time: metformin+ sulfonylurea (Panel a); metformin+ thiazolidinedione (Panel b). Patients are allocated into these drug treatment exposures at treatment intensification persistence on medication is not required. Confidence intervals were calculated using the maximum Harrell-Davis standard error

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us